OTC · Financial Statements
Evofem Biosciences, Inc. (EVFM) Financial Statements
$0.01
OTC: EVFM
Market Cap $1.06M
Overview Financials Dividend
Evofem Biosciences, Inc. most recently reported annual revenue of $20.0M, net profit of $0. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.
Annual Financials (USD)
Metric 2021 2022 2023 2024 2025
Revenue $8.0M $17.0M $18.0M $19.0M $20.0M Operating Profit $-167.0M $-84.0M $-18.0M $-8.0M $1.0M Net Profit $-205.0M $-77.0M $53.0M $-9.0M $0 EPS $-2962.49 $-164.59 $0.05 $-0.09 $0.00 Op Margin -2023.3% -499.6% -98.0% -39.6% 7.1%
Balance Sheet (USD)
Metric 2021 2022 2023 2024 2025
Total Assets $43.0M $25.0M $11.0M $24.0M $20.0M Total Liabilities $142.0M $97.0M $77.0M $95.0M $90.0M Cash $8.0M $3.0M $1.0M $1.0M $1.0M Borrowings $116.0M $71.0M $43.0M $46.0M $55.0M
Cash Flow (USD)
Metric 2021 2022 2023 2024 2025
Operating Cash Flow $-147.0M $-70.0M $-9.0M $-4.0M $-2.0M Investing Cash Flow $-6.0M $-1.0M $0 $-1.0M $0 Financing Cash Flow $-1.0M $24.0M $0 $0 $0 Net Cash Flow $-59.0M $-9.0M $-4.0M $0 $0 Free Cash Flow $-150.0M $-71.0M $-9.0M $-4.0M $-2.0M
Valuation & Return Ratios
Metric Value PEG Ratio 0.00 EV / EBITDA -17.34 FCF Yield -24.33% Quick Ratio 0.05 Interest Coverage -5.00 Return 1Y -20.00% Return 3Y -98.40% Return 5Y —
Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer .